Is MLND or JEPQ a better dividend investment in 2026?

MLND currently yields 188.68% with a 5% 5-year dividend growth rate. JEPQ yields 11.47% with 5% growth. The better choice depends on your goal: MLND offers higher current income.

What is the dividend yield difference between MLND and JEPQ?

MLND has a forward dividend yield of 188.68% ($2.00/share annually). JEPQ yields 11.47% ($6.16/share annually). The yield gap is 177.21 percentage points.

Home › Compare › MLND vs JEPQ

MLND vs JEPQ: Dividend Comparison 2026

MLND yields 188.68% · JEPQ yields 11.47%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MLND wins by $85.50M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MLND

● Live price

188.68%

Share price

$1.06

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$85.54M

Annual income

$41,878,852.89

Full MLND calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.47%

Share price

$53.77

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.8K

Annual income

$2,269.18

Full JEPQ calculator →

Portfolio growth — MLND vs JEPQ

📍 MLND pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MLND	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MLND + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MLND pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MLND

Annual income on $10K today (after 15% tax)

$16,037.74/yr

After 10yr DRIP, annual income (after tax)

$35,597,024.96/yr

JEPQ

Annual income on $10K today (after 15% tax)

$974.55/yr

After 10yr DRIP, annual income (after tax)

$1,928.80/yr

At 15% tax rate, MLND beats the other by $35,595,096.15/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MLND + JEPQ for your $10,000?

MLND: 50%JEPQ: 50%

100% JEPQ50/50100% MLND

Portfolio after 10yr

$42.79M

Annual income

$20,940,561.03/yr

Blended yield

48.93%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MLND right now

MLND

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

-18.3

Piotroski

4/9

JEPQ

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MLND buys

JEPQ buys

No recent congressional trades found for MLND or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMLNDJEPQ

Forward yield	188.68% ✓	11.47%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$85.54M ✓	$45.8K
Annual income after 10y	$41,878,852.89 ✓	$2,269.18
Total dividends collected	$80.35M ✓	$17.1K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: MLND vs JEPQ ($10,000, DRIP)

Year	MLND Portfolio	MLND Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$29,568	$18,867.92	$11,967	$1,146.53	+$17.6K → MLND
2	$83,776	$52,138.82	$14,216	$1,268.02	+$69.6K → MLND
3	$227,704	$138,063.47	$16,774	$1,392.20	+$210.9K → MLND
4	$594,350	$350,706.71	$19,667	$1,518.21	+$574.7K → MLND
5	$1,491,478	$855,522.69	$22,925	$1,645.21	+$1.47M → MLND
6	$3,602,301	$2,006,420.52	$26,578	$1,772.40	+$3.58M → MLND
7	$8,383,454	$4,528,991.67	$30,656	$1,899.04	+$8.35M → MLND
8	$18,820,851	$9,850,554.67	$35,194	$2,024.45	+$18.79M → MLND
9	$40,806,058	$20,667,748.07	$40,228	$2,148.01	+$40.77M → MLND
10	$85,541,335	$41,878,852.89	$45,796	$2,269.18	+$85.50M → MLND

MLND vs JEPQ: Complete Analysis 2026

MLND — Stock

Millendo Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing novel treatments for orphan endocrine diseases in the United States. Its lead product candidates include livoletide, a potential treatment for Prader-Willi syndrome; nevanimibe, a potential treatment for patients with classic congenital adrenal hyperplasia; and MLE-301, a neurokinin 3-receptor antagonist for the treatment of vasomotor symptoms in menopausal women. The company is headquartered in Ann Arbor, Michigan.

Full MLND Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this MLND vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MLND vs SCHD MLND vs JEPI MLND vs O MLND vs KO MLND vs MAIN MLND vs XYLD MLND vs QYLD MLND vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.